Orexo Signs an Exclusive Development Agreement for Its OX17 Program – WELT ONLINE

Posted on by
Orexo Signs an Exclusive Development Agreement for Its OX17 Program
WELT ONLINE, Germany - Feb 8, 2009
Gastroesophageal reflux disease (GERD) is a chronic disease that causes recurrent acid reflux, commonly known as "heart burn.” Symptoms occur when acid …

Source:Orexo Signs an Exclusive Development Agreement for Its OX17 Program – WELT ONLINE

One thought on “Orexo Signs an Exclusive Development Agreement for Its OX17 Program – WELT ONLINE”

  1. Pingback: Randall

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>